By Dr. Mercola
In December 2016, the 21st Century Cures Act was passed by Congress and signed into law by President Obama.
After easily passing through the House of Representatives during the summer of 2015, the bill (H.R. 34) stalled in the Senate until the end of November 2016, when it was put on a fast track and pushed through the Senate with a 94-5 vote.
The nearly 1,000-page Act touts some impressive-sounding rhetoric, like a $1.8-billion investment in cancer research and another $1 billion pledged to fight the abuse of opioids, heroin and other addictive drugs.
Over the next decade, the 21st Century Cures Act pledges $6.3 billion in spending and will “streamline” drug and medical device approvals by the U.S. Food and Drug Administration (FDA)… [read more]
Part of this article:
The relaxed FDA standards will no longer require drug companies to conduct large, randomized and controlled human clinical trials, considered to be the gold standard for proving pharmaceutical product safety, including approval to sell a drug to treat more than one condition.